News & Articles

April 2020 Newsletter – Covid-19 Pandemic

The ALP Newsletter

Dear Reader,

This year has turned out differently than almost anyone could have imagined. In the midst of change and uncertainty our health can be placed in jeopardy from several fronts both acute and chronic. At ALP Life Sciences we remain dedicated to helping people enhance and protect their health. One-way to be proactive is through reducing ones risk of chronic inflammatory diseases. The CDC stated the following:

“Six in ten Americans live with at least one chronic disease, like heart disease and stroke, cancer, or diabetes. These and other chronic diseases are the leading causes of death and disability in America, and they are also a leading driver of health care cost.”

Furthermore, the CDC explains that individuals with underlying conditions are at higher risks for COVID 19 and they state those are,

“People of all ages with underlying medical conditions, particularly if not well controlled, including

  • People with chronic lung disease or moderate to severe asthma
  • People who have serious heart conditions
  • People who are immunocompromised
  • People with severe obesity (BMI of 40 or>)
  • People with diabetes
  • People with chronic kidney disease undergoing dialysis
  • People with liver disease”

According to the National Institutes of Health Omega 3 fatty acids primarily in fish oils have shown to be beneficial in preventing chronic inflammatory disease like “coronary heart disease, hypertension, type 2 diabetes, renal disease, rheumatoid arthritis, ulcerative colitis, Crohn’s disease, and chronic obstructive pulmonary disease.”

Therefore, we recommend you keep supplementing with ALP High-3 to receive the maximum benefit from your omega 3 supplement and reduce your risk of chronic inflammatory diseases.

Stay safe and stay well.


Robert A. Barker, MD

Did you know that your Omega 6/3 Ratio is one of the most important parts of your health? Are you taking the necessary steps to reduce your risk of chronic inflammatory disease and boost your everyday well being? Re-order ALP High-3 Today.
Re-order ALP High-3

The Big Three

Three scholarly research articles to further your understanding of Omega 6/3 Ratios and their roles in reducing Chronic Inflammatory Disease

“Omega-3 polyunsaturated fatty acids (PUFAs) are considered immunonutrients and are commonly used in the nutritional therapy of cancer patients due to their ample biological effects. Omega-3 PUFAs play essential roles in cell signaling and in the cell structure and fluidity of membranes.”
This article describes the connection between Omega 6/3 Ratios and Chronic Obstructive Pulmonary Disease. The connection relates to the impact of Omega 3 fatty acids in modulating COPD.  
Brain Health

“Therefore, the imbalance of the n-6/n-3 ratio can alter cell membrane properties and increase production of inflammatory mediators, suggesting a possible risk factor to neuroinflammation. Thus, a dietary n-6/n-3 ratio control could be a neuroprotection strategy” 


ALP Life Sciences is focused on advancing research in Applied Lipid Polymorphism (ALP – taking good fat to remove and remodel bad fat) to Combat the Global Epidemic of Chronic Inflammatory Disease

Please email us at info@alplifesciences.com or visit our Website
15 Jane Jacobs Rd., Suite 102
Black Mountain, North Carolina 28711
© 2019 ALP Life Sciences, LLC. All Rights Reserved
{{{unsubscribe_link}}} | alplifesciences.com | info@alplifesciences.com 


Want to Receive this Newsletter in your Inbox Each Month?

Fill out my online form